Neurocognition and medication adherence in HIV-infected adults

Social Neuroscience and Public Health: Foundations for the Science of Chronic Disease Prevention

Volumn , Issue , 2013, Pages 85-108

  Panos, Stella E ^a   Patel, Sapna M ^a   Thames, April D ^a   Hinkin, Charles H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84921898990     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-6852-3_6     Document Type: Chapter

References (90)

1. Albert, S. M., Weber, C. M., Todak, G., Polanco, C., Clouse, R., McElhiney, M., et al. (1999). An observed performance test of medication management ability in HIV: Relation to neuropsychological status and medication adherence outcomes. AIDS and Behavior, 3(2), 121-128. doi:10.1023/a:1025483806464.
2. Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., et al. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes, 31(Suppl 3), S123-S127.
3. Ammassari, A., Antinori, A., Aloisi, M. S., Trotta, M. P., Murri, R., Bartoli, L., et al. (2004). Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics, 45(5), 394-402. doi:10.1176/appi.psy.45.5.394.
4. Arentsen, T. J., Panos, S. E., Thames, A. D., Streiff, V., Arbid, N., & Hinkin, C. H. (2012). Psychosocial indicators of medication adherence among cognitively impaired HIV-infected individuals [Abstract]. Proceedings of the 92nd Annual Western Psychological Association Convention, San Francisco, CA
5. Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33(8), 1417-1423. doi:10.1086/323201.
6. Avants, S. K., Margolin, A., Warburton, L. A., Hawkins, K. A., & Shi, J. (2001). Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. The American Journal On Addictions/American Academy of Psychiatrists in Alcoholism and Addictions, 10(1), 69-78.
7. Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., et al. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26(5), 435-442.
8. Barclay, T. R., Hinkin, C. H., Castellon, S. A., Mason, K. I., Reinhard, M. J., Marion, S. D., et al. (2007). Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status. Health Psychology, 26(1), 40-49.
9. Becker, M. H., & Maiman, L. A. (1980). Strategies for enhancing patient compliance. Journal of Community Health, 6(2), 113-135.
10. Becker, S. L., Dezii, C. M., Burtcel, B., Kawabata, H., & Hodder, S. (2002). Young HIV-infected adults are at greater risk for medication nonadherence. Medscape General Medicine, 4(3), 21.
11. Becker, B. W., Thames, A. D., Woo, E., Castellon, S. A., & Hinkin, C. H. (2011). Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS and Behavior, 15(8), 1888-1894. doi:10.1007/s10461-011-9924-z.
12. Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., et al. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58(8), 721-728.
13. Blazer, D. G., Kessler, R. C., McGonagle, K. A., & Swartz, M. S. (1994). The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. The American Journal of Psychiatry, 151(7), 979-986.
14. Bungener, C., Le Houezec, J. L., Pierson, A., & Jouvent, R. (1996). Cognitive and emotional deficits in early stages of HIV infection: An event-related potentials study. Progress in NeuroPsychopharmacology and Biological Psychiatry, 20(8), 1303-1314.
15. Castellon, S. A., Hinkin, C. H., Wood, S., & Yarema, K. T. (1998). Apathy, depression, and cognitive performance in HIV-1 infection. The Journal of Neuropsychiatry and Clinical Neurosciences, 10(3), 320-329.
16. Castellon, S. A., Hinkin, C. H., & Myers, H. F. (2000). Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. Journal of the International Neuropsychological Society, 6(3), 336-347.
17. Castellon, S. A., Hinkin, C. H., Wright, M., & Barclay, T. R. (2009). Neuropsychological Function and Adherence to Medical Treatments. In I. Grant & K. Adams (Eds.), Neuropsychological Assessment Of Neuropsychiatric And Neuromedical Disorders (pp. 688-712).
18. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19(2), 124-133.
19. Centers for Disease Control. (2007). HIV/AIDS Surveillance Report, 2005. (Vol. 17, Rev ed., pp. 1-54). Atlanta, GA: U.S. Department of Health and Human Services.
20. Centers for Disease Control and Prevention. (2009). Chronic Diseases: The Power to Prevent, The Call to Control-At a Glance 2009. Retrieved March 9, 2013, from http://www.cdc.gov/nccdphp/publications/AAG/chronic.htm.
21. Cha, E., Erlen, J. A., Kim, K. H., Sereika, S. M., & Caruthers, D. (2008). Mediating roles of medication-taking self-efficacy and depressive symptoms on self-reported medication adherence in persons with HIV: A questionnaire survey. International Journal of Nursing Studies, 45(8), 1175-1184.
22. Claxton, A. J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics, 23(8), 1296-1310.
23. Cole, M. A., Castellon, S. A., Perkins, A. C., Ureno, O. S., Robinet, M. B., Reinhard, M. J., et al. (2007). Relationship between psychiatric status and frontal-subcortical systems in HIV-infected individuals. Journal of the International Neuropsychological Society, 13(3), 549-554. doi:10.1017/S135561770707066X.
24. Cutler, D. M., Long, G., Berndt, E. R., Royer, J., Fournier, A. A., Sasser, A., et al. (2007). The value of antihypertensive drugs: A perspective on medical innovation. Health Aff (Millwood), 26(1), 97-110. doi:10.1377/hlthaff.26.1.97.
25. Dew, M. A., Becker, J. T., Sanchez, J., Caldararo, R., Lopez, O. L., Wess, J., et al. (1997). Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: A longitudinal evaluation. Psychological Medicine, 27(2), 395-409.
26. Ettenhofer, M. L., Hinkin, C. H., Castellon, S. A., Durvasula, R., Ullman, J., & Lam, M. (2009). Aging, neurocognition, and medication adherence in HIV infection. The American Journal of Geriatric Psychiatry, 17(4), 281-290. doi:10.1097/JGP.0b013e31819431bd.
27. Ettenhofer, M. L., Foley, J., Castellon, S. A., & Hinkin, C. H. (2010). Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology, 74(15), 1217-1222.
28. Farmer, M. E., Kittner, S. J., Abbott, R. D., Wolz, M. M., Wolf, P. A., & White, L. R. (1990). Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: The Framingham study. Journal of Clinical Epidemiology, 43(5), 475-480.
29. Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Education and Counseling, 46(2), 93-108.
30. Gao, X., Nau, D. P., Rosenbluth, S. A., Scott, V., & Woodward, C. (2000). The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS care, 12(4), 387-398. doi:10.1080/09540120050123783.
31. Geller, J. L. (1982). State hospital patients and their medication-do they know what they take? The American Journal of Psychiatry, 139(5), 611-615.
32. Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23(5), 386-395.
33. Gonzalez, J. S., Penedo, F. J., Antoni, M. H., Duran, R. E., McPherson-Baker, S., Ironson, G., et al. (2004). Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology, 23(4), 413-418. doi:10.1037/0278-6133.23.4.413.
34. Gorman, A. A., Foley, J. M., Ettenhofer, M. L., Hinkin, C. H., & van Gorp, W. G. (2009). Functional consequences of HIV-associated neuropsychological impairment. Neuropsychology Review, 19(2):186-203. doi:10.1007/s11065-009-9095-0
35. Gould, O. N., McDonald-Miszczak, L., & Gregory, J. (1999). Prediction accuracy and medication instructions: Will you remember tomorrow. Aging, Neuropsychology, and Cognition, 6, 141-154.
36. Greene, J. Y., Weinberger, M., Jerin, M. J., & Mamlin, J. J. (1982). Compliance with medication regimens among chronically ill, inner city patients. Journal of Community Health, 7(3), 183-193.
37. Halkitis, P., Palamar, J., & Mukherjee, P. (2008). Analysis of HIV medication adherence in relation to person and treatment characteristics using hierarchical linear modeling. AIDS Patient Care and STDs, 22(4), 323-335. doi:10.1089/apc.2007.0122.
38. Hall, P. A., & Fong, G. T. (2007). Teporal self-regulation theory: A model for individual health behavior. Health Psychology Review, 1(1), 6-52. doi:10.1080/17437190701492437.
39. Hall, P. A., Fong, G. T., Epp, L. J., & Elias, L. J. (2008). Executive function moderates the intention-behavior link for physical activity and dietary behavior. Psychology and Health, 23(3), 309-326. doi:10.1080/14768320701212099.
40. Harberer, J. E., Robbins, G. K., Ybarra, M., Monk, A., Ragland, K., Weiser, S. D., et al. (2012). Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behavior, 16(2), 375-382.
41. Hayes, T. L., Hunt, J. M., Adami, A., & Kaye, J. A. (2006). An electronic pillbox for continuous monitoring of medication adherence.Proceedings of the 27th Annual International Conference of the IEE Engineering in Medicine and Biology Society, New York.
42. Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H. et al. (1995). The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. Journal of the International Neuropsychological Society, 1(3), 231-251.
43. Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J., Moore, D. J., Bentley, H., et al. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society, 10(3), 317-331. doi:10.1017/s1355617704102130.
44. Hinkin, C. H., Cummings, J. L., van Gorp, W. G., Satz, P., Mitrushina, M., & Freeman, D. (1990). Frontal/subcortical features of normal aging: An empirical analysis. Canadian Journal on Aging, 9, 104-119.
45. Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., & Stefaniak, M. (2002a). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59(12), 1944-1950.
46. Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Lam, M. N., Stefaniak, M., & Zolnikov, B. (2002b). Verbal and spatial working memory performance among HIV-infected adults. Journal of the International Neuropsychological Society, 8(4), 532-538.
47. Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18(Suppl 1), S19-S25.
48. Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., et al. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11(2), 185-194. doi:10.1007/s10461-006-9152-0.
49. HIV Prevention Trials Network. (2011). Initiation of antiretroviral treatment protects uninfected sexual partners from HIV Infection (HPTN Study 052) [Press Release]. Retrieved from http://www.hptn.org/web%20documents/PressReleases/HPTN052PressReleaseFINAL5_12_118am.pdf.
50. Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., et al. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16(16), 2175-2182.
51. Ickovics, J. R., & Meisler, A. W. (1997). Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal of Clinical Epidemiology, 50(4), 385-391.
52. Ingersoll, K. S., & Cohen, J. (2008). The impact of medication regimen factors on adherence to chronic treatment: A review of literature. Journal of Behavioral Medicine, 31(3), 213-224. doi:10.1007/s10865-007-9147-y.
53. Iskedjian, M., Einarson, T. R., MacKeigan, L. D., Shear, N., Addis, A., Mittmann, N., et al. (2002). Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis. Clinical Therapeutics, 24(2), 302-316.
54. Johnson, M. O., Chesney, M. A., Goldstein, R. B., Remien, R. H., Catz, S., Gore-Felton, C., et al. (2006). Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model. AIDS Patient Care and STDs, 20(4), 258-268.
55. Kalichman, S. C., Ramachandran, B., & Catz, S. (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Journal of General Internal Medicine, 14(5), 267-273.
56. Kalichman, S. C., Cherry, J., & Cain, D. (2005). Nurse-delivered antiretroviral treatment adherence intervention for people with low literacy skills and living with HIV/AIDS. The Journal of the Association of Nurses in AIDS Care, 16(5), 3-15.
57. Levine, A. J., Hinkin, C. H., Marion, S., Keuning, A., Castellon, S. A., Lam, M. M., et al. (2006). Adherence to antiretroviral medications in HIV: Differences in data collected via self-report and electronic monitoring. Health Psychology, 25(3), 329-335. doi:10.1037/0278-6133.25.3.329.
58. Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., & Wenger, N. S. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134(10), 968-977.
59. Lovejoy, T. I., & Suhr, J. A. (2009). The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: A systematic review. Journal of Behavioral Medicine, 32(5), 389-405. doi:10.1007/s10865-009-9212-9.
60. Malta, M., Strathdee, S. A., Magnanini, M. M., & Bastos, F. I. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103(8), 1242-1257. doi:10.1111/j.1360-0443.2008.02269.x.
61. Malta, M., Magnanini, M. M., Strathdee, S. A., & Bastos, F. I. (2010). Adherence to antiretroviral therapy among HIV-infected drug users: A meta-analysis. AIDS and Behavior, 14(4), 731-747. doi:10.1007/s10461-008-9489-7.
62. McDaniel, M. A., & Einstein, G. O. (2007). Prospective memory: An overview and synthesis of an emerging field. Thousand Oaks: Sage Publications.
63. McDonnell, P. J., & Jacobs, M. R. (2002). Hospital admissions resulting from preventable adverse drug reactions. The Annals of Pharmacotherapy, 36(9), 1331-1336.
64. Meade, C. S., Conn, N. A., Skalski, L. M., & Safren, S. A. (2011). Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. Journal of Behavioral Medicine, 34(2), 128-138. doi:10.1007/s10865-010-9293-5.
65. Meyer, M. E., & Schuna, A. A. (1989). Assessment of geriatric patients’ functional ability to take medication. DICP, 23(2), 171-174.
66. Nieuwkerk, P. T., Sprangers, M. A., Burger, D. M., Hoetelmans, R. M., Hugen, P. W., Danner, S. A., et al. (2001). Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Archives of Internal Medicine,161(16), 1962-1968.
67. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. The New England Journal of Medicine, 353(5), 487-497. doi:10.1056/NEJMra050100.
68. Panos, S. E., Del Re, A., Thames, A. D., Levine, A. J., Streiff, V., Castellon, S. A., et al. (2011). Predictors of longitudinal medication adherence: Evidence from an integrative model [Abstract]. The Clinical Neuropsychologist, 25(4), 556.
69. Parkin, D. M., Henney, C. R., Quirk, J., & Crooks, J. (1976). Deviation from prescribed drug treatment after discharge from hospital. British Medical Journal, 2(6037), 686-688.
70. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21-30.
71. Paul, R., Flanigan, T. P., Tashima, K., Cohen, R., Lawrence, J., Alt, E., et al. (2005). Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus. The Journal of Neuropsychiatry and Clinical Neurosciences, 17(1), 114-118. doi:10.1176/appi.neuropsych.17.1.114.
72. Rabkin, J. G. (1996). Prevalence of psychiatric disorders in HIV illness. International Review of Psychiatry, 8(2-3), 157-166. doi:10.3109/09540269609046300.
73. Robertson, K., Liner, J., & Heaton, R. (2009). Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychology Review, 19(2), 232-249. doi:10.1007/s11065-009-9096-z.
74. Rosenstock, I. M. (1974). Historical origins of the health belief model. Health Education Monographs, 2, 1-8.
75. Sabaté, E. (2003). Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization.
76. Shah, S. S., McGowan, J. P., Smith, C., Blum, S., & Klein, R. S. (2002). Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clinical Infectious Diseases, 35(10), 1238-1243. doi:10.1086/343048.
77. Simoni, J. M., Frick, P. A., & Huang, B. (2006). A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychology, 25(1), 74-81.
78. Simons, J. S., Scholvinck, M. L., Gilbert, S. J., Frith, C. D., & Burgess, P. W. (2006). Differential components of prospective memory? Evidence from fMRI. Neuropsychologia, 44, 1388-1397. doi:10.1016/j.neuropsychologia.2006.01.005.
79. Thames, A. D., Becker, B. W., Marcotte, T. D., Hines, L. J., Foley, J. M., Ramezani, A., & Hinkin, C. H. (2011a). Depression, cognition, and self-appraisal of functional abilities in HIV: An examination of subjective appraisal versus objective performance. The Clinical Neuropsychologist, 25(2), 224-243. doi:10.1080/13854046.2010.539577.
80. Thames, A. D., Kim, M. S., Becker, B. W., Foley, J. M., Hines, L. J., Singer, E. J., Hinkin, C. H. (2011b). Medication and finance management among HIV-infected adults: The impact of age and cognition. Journal of Clinical and Experimental Neuropsychology, 33(2), 200-209. doi: 10.1080/13803395.2010.499357.
81. Thames, A. D., Moizel, J., Panos, S. E., Patel, S. M., Byrd, D. A., Myers, H. F., Hinkin, C. H. (2012). Differential predictors of medication adherence among African American and Caucasian HIV+ adults. AIDS Patient Care and STDs, 26(10), 621-630. doi:10.1089/apc.2012.0157.
82. US Department of Health and Human Services Office of Disease Prevention and Health Promotion. (2010). National Action Plan to Improve Health Literacy. Washington: Author.
83. US Food and Drug Administration. (2012). FDA Approves first drug for reducing the risk of sexually acquired HIV infection [Press Release]. Retrieved from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312210.htm.
84. Valcour, V., Shikuma, C., Shiramizu, B., Watters, M., Poff, P., Selnes, O., et al. (2004). Higher frequency of dementia in older HIV-1 individuals: The Hawaiian aging with HIV-1 Cohort. Neurology, 63(5), 822-827.
85. Vik, S. A., Hogan, D. B., Patten, S. B., Johnson, J. A., Romonko-Slack, L., & Maxwell, C. J. (2006). Medication nonadherence and subsequent risk of hospitalisation and mortality among older adults. Drugs and Aging, 23(4), 345-356.
86. Waldrop-Valverde, D., Jones, D. L., Gould, F., Kumar, M., & Ownby, R. L. (2010). Neurocognition, health-related reading literacy, and numeracy in medication management for HIV infection. AIDS Patient Care and STDs, 24(8), 477-484. doi:10.1089/apc.2009.0300.
87. Wendelken, L. A., & Valcour, V. (2012). Impact of HIV and aging on neuropsychological function. Journal of Neurovirology, 18(4), 256-263. doi:10.1007/s13365-012-0094-1.
88. Wilkie, F. L., Goodkin, K., van Zuilen, M. H., Tyll, M. D., Lecusay, R., & Edwin, T. (2000). Cognitive effects of HIV-1 infection. CNS Spectrums, 5(5), 33-51.
89. Woods, S. P., Moran, L. M., Carey, C. L., Dawson, M. S., Iudicello, J. E., Gibson, S., et al. (2008). Prospective memory in HIV infection: Is “remembering to remember” a unique predictor of self-reported medication management? Archives of Clinical Neuropsychology, 23(3), 257-270. doi:10.1016/j.acn.2007.12.006.
90. Woods, S. P., Dawson, M. S., Weber, E., Gibson, S., Grant, I., & Atkinson, J. H. (2009). Timing is everything: Antiretroviral nonadherence is associated with impairment in time-based prospective memory. Journal of the International Neuropsychological Society, 15(1), 42-52. doi:10.1017/s1355617708090012.